Non-invasive approaches to monitor EGFR-TKI treatment in non-small-cell lung cancer

Non-invasive approaches to monitor EGFR-TKI treatment in non-small-cell lung cancer

Tyrosine kinase inhibitors of epidermal growth factor receptor (EGFR-TKIs) are standard treatments for advanced non-small-cell lung cancer (NSCLC) patients harboring activating epidermal growth factor receptor (EGFR) mutations. Nowadays, tumor tissues acquired by surgery or biopsy are the routine ma...

Full description

Bibliographic Details
Main Authors: Sun, Wei, Yuan, Xun, Tian, Yijun, Wu, Hua, Xu, Hanxiao, Hu, Guoqing, Wu, Kongming
Format: Online
Language:English
Published: BioMed Central 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4521383/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4521383/

Similar Items